{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:48:05Z","timestamp":1787064485867,"version":"build-2736575974"},"reference-count":59,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T00:00:00Z","timestamp":1565654400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Fresenius Medical Care Deutschland GmbH"},{"DOI":"10.13039\/100004702","name":"Baxter International","doi-asserted-by":"publisher","award":["11CECHHDEU1004"],"award-info":[{"award-number":["11CECHHDEU1004"]}],"id":[{"id":"10.13039\/100004702","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Nierstichting (NL)","award":["SB166"],"award-info":[{"award-number":["SB166"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0221058","type":"journal-article","created":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T13:26:38Z","timestamp":1565702798000},"page":"e0221058","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":33,"title":["Relations of advanced glycation endproducts and dicarbonyls with endothelial dysfunction and low-grade inflammation in individuals with end-stage renal disease in the transition to renal replacement therapy: A cross-sectional observational study"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4632-6412","authenticated-orcid":true,"given":"Remy J. H.","family":"Martens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natascha J. H.","family":"Broers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Canaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3558-2277","authenticated-orcid":true,"given":"Maarten H. L.","family":"Christiaans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Cornelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2554-0711","authenticated-orcid":true,"given":"Adelheid","family":"Gauly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc M. H.","family":"Hermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantijn J. A. M.","family":"Konings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank M.","family":"van der Sande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean L. J. M.","family":"Scheijen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Stifft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joris J. J. M.","family":"Wirtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen P.","family":"Kooman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casper G.","family":"Schalkwijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,8,13]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2215\/CJN.01170905","article-title":"Predictors of early mortality among incident US hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"2","author":"BD Bradbury","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"ref2","doi-asserted-by":"crossref","first-page":"e0126048","DOI":"10.1371\/journal.pone.0126048","article-title":"Free Levels of Selected Organic Solutes and Cardiovascular Morbidity and Mortality in Hemodialysis Patients: Results from the Retained Organic Solutes and Clinical Outcomes (ROSCO) Investigators","volume":"10","author":"T Shafi","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/CIRCULATIONAHA.106.678342","article-title":"Chronic kidney disease: effects on the cardiovascular system","volume":"116","author":"EL Schiffrin","year":"2007","journal-title":"Circulation"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.med.58.071105.111123","article-title":"Kidney disease and cardiovascular risk","volume":"58","author":"M Tonelli","year":"2007","journal-title":"Annu Rev Med"},{"issue":"9889","key":"ref5","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0140-6736(13)60595-4","article-title":"Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention","volume":"382","author":"RT Gansevoort","year":"2013","journal-title":"Lancet"},{"issue":"6","key":"ref6","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1161\/CIRCULATIONAHA.106.621854","article-title":"Advanced glycation end products: sparking the development of diabetic vascular injury","volume":"114","author":"A Goldin","year":"2006","journal-title":"Circulation"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0272-6386(00)70189-2","article-title":"Advanced glycation end products: a Nephrologist's perspective","volume":"35","author":"DS Raj","year":"2000","journal-title":"Am J Kidney Dis"},{"issue":"6865","key":"ref8","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","article-title":"Biochemistry and molecular cell biology of diabetic complications","volume":"414","author":"M Brownlee","year":"2001","journal-title":"Nature"},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bbrc.2015.01.140","article-title":"Dicarbonyl stress in cell and tissue dysfunction contributing to ageing and disease","volume":"458","author":"N Rabbani","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"ref10","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.kint.2017.11.034","article-title":"Advanced glycation end products in the pathogenesis of chronic kidney disease","volume":"93","author":"N Rabbani","year":"2018","journal-title":"Kidney Int"},{"issue":"8","key":"ref11","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1007\/s00125-015-3597-5","article-title":"Vascular AGE-ing by methylglyoxal: the past, the present and the future","volume":"58","author":"CG Schalkwijk","year":"2015","journal-title":"Diabetologia"},{"issue":"12","key":"ref12","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1042\/CS20140683","article-title":"The role of methylglyoxal and the glyoxalase system in diabetes and other age-related diseases","volume":"128","author":"DE Maessen","year":"2015","journal-title":"Clin Sci (Lond)"},{"issue":"17","key":"ref13","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1093\/eurheartj\/eht402","article-title":"Higher levels of advanced glycation endproducts in human carotid atherosclerotic plaques are associated with a rupture-prone phenotype","volume":"35","author":"NM Hanssen","year":"2014","journal-title":"Eur Heart J"},{"issue":"8912","key":"ref14","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(94)92935-1","article-title":"Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure","volume":"343","author":"Z Makita","year":"1994","journal-title":"Lancet"},{"issue":"6","key":"ref15","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1046\/j.1523-1755.2000.00117.x","article-title":"Mechanisms for the formation of glycoxidation products in end-stage renal disease","volume":"57","author":"MF Weiss","year":"2000","journal-title":"Kidney Int"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1196\/annals.1333.027","article-title":"Evaluation of glyoxal and methylglyoxal levels in uremic patients under peritoneal dialysis","volume":"1043","author":"A Lapolla","year":"2005","journal-title":"Ann N Y Acad Sci"},{"issue":"12","key":"ref17","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1681\/ASN.2005020144","article-title":"Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients","volume":"16","author":"R Meerwaldt","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"19\u201320","key":"ref18","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.cca.2010.06.019","article-title":"Mechanism of endothelial dysfunction in chronic kidney disease","volume":"411","author":"J Malyszko","year":"2010","journal-title":"Clin Chim Acta"},{"issue":"5","key":"ref19","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1525-139X.2010.00784.x","article-title":"Inflammation in end-stage renal disease\u2014what have we learned in 10 years?","volume":"23","author":"JJ Carrero","year":"2010","journal-title":"Semin Dial"},{"issue":"6","key":"ref20","first-page":"S21","article-title":"Enhanced plasma levels of advanced glycation end products (AGE) and pro-inflammatory cytokines in children\/adolescents with chronic renal insufficiency and after renal replacement therapy by dialysis and transplantation\u2014are they inter-related?","volume":"56","author":"K Sebekova","year":"2001","journal-title":"Clin Nephrol"},{"issue":"4","key":"ref21","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1159\/000054727","article-title":"Marked increases in macrophage colony-stimulating factor and interleukin-18 in maintenance hemodialysis patients: comparative study of advanced glycation end products, carboxymethyllysine and pentosidine","volume":"90","author":"T Uchimura","year":"2002","journal-title":"Nephron"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1046\/j.1523-1755.2002.00423.x","article-title":"Advanced glycation end products and mortality in hemodialysis patients","volume":"62","author":"SB Schwedler","year":"2002","journal-title":"Kidney Int"},{"issue":"6","key":"ref23","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1097\/01.ASN.0000067413.32377.CF","article-title":"Plasma pentosidine is associated with inflammation and malnutrition in end-stage renal disease patients starting on dialysis therapy","volume":"14","author":"ME Suliman","year":"2003","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"ref24","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1055\/s-2006-956501","article-title":"Correlation between pentosidine and endothelin-1 in subjects undergoing chronic hemodialysis","volume":"38","author":"P Odetti","year":"2006","journal-title":"Horm Metab Res"},{"issue":"3","key":"ref25","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1440-1797.2010.01419.x","article-title":"Tissue level of advanced glycation end products is an independent determinant of high-sensitivity C-reactive protein levels in haemodialysis patients","volume":"16","author":"M Nagano","year":"2011","journal-title":"Nephrology (Carlton)"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","first-page":"e0147771","DOI":"10.1371\/journal.pone.0147771","article-title":"Skin Autofluorescence Is Associated with Endothelial Dysfunction in Uremic Subjects on Hemodialysis","volume":"11","author":"CC Wang","year":"2016","journal-title":"PloS one"},{"issue":"5","key":"ref27","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1177\/1479164113486662","article-title":"Involvement of advanced glycation end product-induced asymmetric dimethylarginine generation in endothelial dysfunction","volume":"10","author":"R Ando","year":"2013","journal-title":"Diab Vasc Dis Res"},{"key":"ref28","article-title":"Skin autofluorescence, arterial stiffness and Framingham risk score as predictors of clinical outcome in chronic kidney disease patients: a cohort study","author":"H Mukai","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"ref29","article-title":"The Association of Nutritional Factors and Skin Autofluorescence in Persons Receiving Hemodialysis","author":"D Viramontes Horner","year":"2018","journal-title":"J Ren Nutr"},{"issue":"6","key":"ref30","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1097\/01.ASN.0000067413.32377.CF","article-title":"Plasma pentosidine is associated with inflammation and malnutrition in end-stage renal disease patients starting on dialysis therapy","volume":"14","author":"ME Suliman","year":"2003","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"ref31","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1093\/ndt\/gfv038","article-title":"Protein-bound uraemic toxins, dicarbonyl stress and advanced glycation end products in conventional and extended haemodialysis and haemodiafiltration","volume":"30","author":"T Cornelis","year":"2015","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3747\/pdi.2010.00101","article-title":""NEPP" peritoneal dialysis regimen has beneficial effects on plasma CEL and 3-DG, but not pentosidine, CML, and MGO","volume":"32","author":"CY le Poole","year":"2012","journal-title":"Perit Dial Int"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000476072","article-title":"Physical Activity in End-Stage Renal Disease Patients: The Effects of Starting Dialysis in the First 6 Months after the Transition Period","volume":"137","author":"NJH Broers","year":"2017","journal-title":"Nephron"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12882-019-1299-9","article-title":"Living-donor transplantation leads to a major improvement in physical functioning: an observational study on the impact on potential donors and their recipients","volume":"20","author":"NJH Broers","year":"2019","journal-title":"BMC Nephrol"},{"issue":"8","key":"ref35","doi-asserted-by":"crossref","first-page":"E1369","DOI":"10.1210\/jc.2013-1068","article-title":"Plasma levels of advanced glycation endproducts Nepsilon-(carboxymethyl)lysine, Nepsilon-(carboxyethyl)lysine, and pentosidine are not independently associated with cardiovascular disease in individuals with or without type 2 diabetes: the Hoorn and CODAM studies","volume":"98","author":"NM Hanssen","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"ref36","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1515\/cclm-2012-0878","article-title":"Quantification of glyoxal, methylglyoxal and 3-deoxyglucosone in blood and plasma by ultra performance liquid chromatography tandem mass spectrometry: evaluation of blood specimen","volume":"52","author":"JL Scheijen","year":"2014","journal-title":"Clin Chem Lab Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1196\/annals.1333.036","article-title":"Simple noninvasive measurement of skin autofluorescence","volume":"1043","author":"R Meerwaldt","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"ref38","unstructured":"DiagnOptics Technologies BV Groningen The Netherlands. AGE Reader CU User Manual\u2014Instructions for Use\u2014Version 1.2."},{"issue":"9","key":"ref39","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"AS Levey","year":"2009","journal-title":"Ann Intern Med"},{"issue":"4","key":"ref40","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1161\/01.ATV.19.4.972","article-title":"C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?","volume":"19","author":"JS Yudkin","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"ref41","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jdiacomp.2015.11.005","article-title":"Markers of inflammation and endothelial dysfunction are associated with incident cardiovascular disease, all-cause mortality, and progression of coronary calcification in type 2 diabetic patients with microalbuminuria","volume":"30","author":"BJ von Scholten","year":"2016","journal-title":"J Diabetes Complications"},{"key":"ref42","unstructured":"R Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2018."},{"key":"ref43","article-title":"RStudio: Integrated Development for R","year":"2016"},{"issue":"3","key":"ref44","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2215\/CJN.04291007","article-title":"Endothelial dysfunction in patients with chronic kidney disease results from advanced glycation end products (AGE)-mediated inhibition of endothelial nitric oxide synthase through RAGE activation","volume":"3","author":"E Linden","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"ref45","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.4049\/jimmunol.161.5.2524","article-title":"Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure","volume":"161","author":"V Witko-Sarsat","year":"1998","journal-title":"J Immunol"},{"issue":"5","key":"ref46","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1681\/ASN.2004080635","article-title":"Profound mishandling of protein glycation degradation products in uremia and dialysis","volume":"16","author":"S Agalou","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"ref47","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1172\/JCI200318921","article-title":"C-reactive protein: a critical update","volume":"111","author":"MB Pepys","year":"2003","journal-title":"J Clin Invest"},{"issue":"1","key":"ref48","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s10020-018-0047-0","article-title":"Serum amyloid A\u2014a review","volume":"24","author":"GH Sack Jr","year":"2018","journal-title":"Mol Med"},{"issue":"3","key":"ref49","first-page":"132","article-title":"Vascular effects of exercise: endothelial adaptations beyond active muscle beds","volume":"26","author":"J Padilla","year":"2011","journal-title":"Physiology (Bethesda)"},{"issue":"1","key":"ref50","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/MNH.0000000000000465","article-title":"Methylglyoxal stress, the glyoxalase system, and diabetic chronic kidney disease","volume":"28","author":"NMJ Hanssen","year":"2019","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"4","key":"ref51","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/EDE.0b013e3181a819a1","article-title":"Overadjustment bias and unnecessary adjustment in epidemiologic studies","volume":"20","author":"EF Schisterman","year":"2009","journal-title":"Epidemiology"},{"issue":"10","key":"ref52","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/rheumatology\/ken302","article-title":"Skin autofluorescence is increased in systemic lupus erythematosus but is not reflected by elevated plasma levels of advanced glycation endproducts","volume":"47","author":"HL Nienhuis","year":"2008","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"ref53","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cardfail.2008.03.008","article-title":"Skin-autofluorescence, a measure of tissue advanced glycation end-products (AGEs), is related to diastolic function in dialysis patients","volume":"14","author":"JW Hartog","year":"2008","journal-title":"J Card Fail"},{"issue":"4","key":"ref54","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.metabol.2010.04.001","article-title":"Advanced glycation end products, carotid atherosclerosis, and circulating endothelial progenitor cells in patients with end-stage renal disease","volume":"60","author":"H Ueno","year":"2011","journal-title":"Metabolism"},{"issue":"14","key":"ref55","doi-asserted-by":"crossref","first-page":"9121","DOI":"10.1016\/S0021-9258(17)47274-7","article-title":"A platelet membrane protein expressed during platelet activation and secretion. Studies using a monoclonal antibody specific for thrombin-activated platelets","volume":"259","author":"S Hsu-Lin","year":"1984","journal-title":"J Biol Chem"},{"issue":"1","key":"ref56","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1172\/JCI114175","article-title":"GMP-140, a platelet alpha-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies","volume":"84","author":"RP McEver","year":"1989","journal-title":"J Clin Invest"},{"issue":"1","key":"ref57","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1084\/jem.175.1.185","article-title":"Intercellular adhesion molecule 3, a third adhesion counter-receptor for lymphocyte function-associated molecule 1 on resting lymphocytes","volume":"175","author":"AR de Fougerolles","year":"1992","journal-title":"J Exp Med"},{"issue":"2","key":"ref58","first-page":"465","article-title":"Intercellular adhesion molecule-3 on endothelial cells. Expression in tumors but not in inflammatory responses","volume":"148","author":"N Patey","year":"1996","journal-title":"Am J Pathol"},{"issue":"9","key":"ref59","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1007\/s00125-016-4009-1","article-title":"Energy restriction and Roux-en-Y gastric bypass reduce postprandial alpha-dicarbonyl stress in obese women with type 2 diabetes","volume":"59","author":"DE Maessen","year":"2016","journal-title":"Diabetologia"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0221058","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T22:32:40Z","timestamp":1695076360000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0221058"}},"subtitle":[],"editor":[{"given":"Ram","family":"Nagaraj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,8,13]]},"references-count":59,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,8,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0221058","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,13]]}}}